Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1976 Sep;10(3):503–506. doi: 10.1128/aac.10.3.503

Effect of Organic Mercurials and Sulfhydryl Compounds on the Urease Activity of Proteus: Inhibition by Urine and Ascorbic Acid

Calvin M Kunin *
PMCID: PMC429779  PMID: 10828

Abstract

Meralluride, mercaptomerin, ethacrynic acid, and penicillamine inhibited urease activity of Proteus mirabilis. The activity of the organic mercurials and ethacrynic acid was markedly inhibited by human and dog urine. Antiurease activity could not be detected in the urine of a human and a dog given meralluride by injection. Urine from patients receiving penicillamine also failed to inhibit urease activity. Ascorbic acid inhibited, whereas dehydroascorbic acid enhanced, the activity of the mercurials, but neither agent altered the inhibitory effect of urine. The lethal effect of meralluride against Proteus occurred at the same concentration at which urease activity was inhibited, but penicillamine inhibited the enzymatic activity without affecting viability of the organism. The data suggest that these sulfhydryl-reactive compounds will not be useful against Proteus infections of the urinary tract.

Full text

PDF
503

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andersen J. A. Benurestat, a urease inhibitor for the therapy of infected ureolysis. Invest Urol. 1975 Mar;12(5):381–386. [PubMed] [Google Scholar]
  2. Aronson M., Medalia O., Griffel B. Prevention of ascending pyelonephritis in mice by urease inhibitors. Nephron. 1974;12(2):94–104. doi: 10.1159/000180271. [DOI] [PubMed] [Google Scholar]
  3. Gibbs K., Walshe J. M. Studies with 35S-labelled DL-penicillamine in patients with Wilson's disease. Q J Med. 1971 Apr;40(158):275–287. doi: 10.1093/oxfordjournals.qjmed.a067270. [DOI] [PubMed] [Google Scholar]
  4. King C. G. Present knowledge of ascorbic acid (vitamin C). Nutr Rev. 1968 Feb;26(2):33–36. doi: 10.1111/j.1753-4887.1968.tb00850.x. [DOI] [PubMed] [Google Scholar]
  5. LATTIMER J. K., SENECA H., ZINSSER H. H., DONOVAN J. T. Drug-resistant bacteria made drug-susceptible by enzyme inhibitors. JAMA. 1961 Nov 18;178:764–766. doi: 10.1001/jama.1961.73040460034017c. [DOI] [PubMed] [Google Scholar]
  6. Mapson L. W. Inhibition of urease by copper salts in the presence of ascorbic acid and related substances. Biochem J. 1946;40(2):240–247. [PMC free article] [PubMed] [Google Scholar]
  7. Musher D. M., Griffith D. P., Tyler M., Woelfel A. Potentiation of the antibacterial effect of methenamine by acetohydroxamic acid. Antimicrob Agents Chemother. 1974 Feb;5(2):101–105. doi: 10.1128/aac.5.2.101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Musher D. M., Griffith D. P., Yawn D., Rossen R. D. Role of urease in pyelonephritis resulting from urinary tract infection with Proteus. J Infect Dis. 1975 Feb;131(2):177–181. doi: 10.1093/infdis/131.2.177. [DOI] [PubMed] [Google Scholar]
  9. SENECA H., LATTIMER J. K., ZINSSER H. H. The chemotherapy of urease- and citrase-producing bacteria of the urinary tract. Ann Intern Med. 1960 Sep;53:468–474. doi: 10.7326/0003-4819-53-3-468. [DOI] [PubMed] [Google Scholar]
  10. WEINER I. M., MULLER O. H. A polarographic study of mersalyl (salyrgan)-thiol complexes and of the excreted products of mersalyl. J Pharmacol Exp Ther. 1955 Mar;113(3):241–249. [PubMed] [Google Scholar]
  11. WILLS E. D., WORMALL A. Studies on suramin; the action of the drug on some enzymes. Biochem J. 1950 Aug;47(2):158–170. doi: 10.1042/bj0470158. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES